Smith Susan Laura

Insider profile

Performance

Overall performance
3.2

Performance over holding periods
3.2
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Smith Susan Laura's trades of Y-mAbs Therapeutics, Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-07 2025-03-07 PrS Proposed sale
72,540
138.93
US$3,468,835
72,540 138.93 US$3,468,835
2024-03-07 2024-03-05 S Sale
74,007 -33.4%
341.13
US$2,132,383
74,007 -33.4% 341.13 US$2,132,383
2024-03-06 2024-03-05 PrS Proposed sale
29,626
281.65
US$3,618,316
29,626 281.65 US$3,618,316